The study by Karagkounis et al. (2013), which is discussed by Wei and Samp on page 460, looked at the incidence and prognostic significance of KRAS (codons 12, 13) and BRAFV600E mutations in patients with metastatic CRC undergoing liver metastasectomy. The gene discussed is KRAS; the disease is colorectal carcinoma.